Cargando…

Metabolomic Approach to Screening Homozygotes in Chinese Patients with Severe Familial Hypercholesterolemia

Homozygous familial hypercholesterolemia (HoFH) is a rare inborn-errors-of-metabolism disorder characterized by devastatingly elevated low-density lipoprotein cholesterol (LDL-C) and premature cardiovascular disease. The gold standard for screening and diagnosing HoFH is genetic testing. In China, i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Zhiyong, Du, Yunhui, Li, Linyi, Sun, Haili, Hu, Chaowei, Jiang, Long, Wang, Luya, Qin, Yanwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861332/ https://www.ncbi.nlm.nih.gov/pubmed/36675412 http://dx.doi.org/10.3390/jcm12020483

Ejemplares similares

Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia
por: Du, Zhiyong, et al.
Publicado: (2023)

Low-density lipoprotein receptor genotypes modify the sera metabolome of patients with homozygous familial hypercholesterolemia
por: Du, Zhiyong, et al.
Publicado: (2022)

Comprehensive Metabolomics and Machine Learning Identify Profound Oxidative Stress and Inflammation Signatures in Hypertensive Patients with Obstructive Sleep Apnea
por: Du, Zhiyong, et al.
Publicado: (2022)

Mutation detection in Chinese patients with familial hypercholesterolemia
por: Du, Ran, et al.
Publicado: (2016)

Functional Characterization of Two Low-Density Lipoprotein Receptor Gene Mutations in Two Chinese Patients with Familial Hypercholesterolemia
por: Wang, Haihong, et al.
Publicado: (2014)

Severe rhabdomyolysis in homozygote carnitine palmitoyltransferase II deficiency
por: Schnedl, Wolfgang J., et al.
Publicado: (2020)

ANGPTL3 and Cardiovascular Outcomes in Patients With Acute Coronary Syndrome and Obstructive Sleep Apnea
por: Lv, Qianwen, et al.
Publicado: (2022)

Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia
por: Lv, Xian, et al.
Publicado: (2023)

ANGPTL8 deletion attenuates abdominal aortic aneurysm formation in ApoE(−/−) mice
por: Yu, Huahui, et al.
Publicado: (2023)

Cascade Screening for Familial Hypercholesterolemia (FH)
por: Ned, Renée M., et al.
Publicado: (2011)

Clinician Perspectives on Clinical Decision Support for Familial Hypercholesterolemia
por: Bangash, Hana, et al.
Publicado: (2023)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotection
por: Henao‐Restrepo, Julián, et al.
Publicado: (2022)

Genetics, Screening, and Treatment of Familial Hypercholesterolemia: Experience Gained From the Implementation of the Vietnam Familial Hypercholesterolemia Registry
por: Truong, Thanh-Huong, et al.
Publicado: (2020)

The burden of severe hypercholesterolemia and familial hypercholesterolemia in a population-based setting in the US
por: Saadatagah, Seyedmohammad, et al.
Publicado: (2022)

Prevalence and Treatment of Familial Hypercholesterolemia and Severe Hypercholesterolemia in Older Adults in Ontario, Canada
por: Akioyamen, Leo E., et al.
Publicado: (2022)

Genetic screening for homozygous and heterozygous familial hypercholesterolemia
por: Izar, Maria C, et al.
Publicado: (2010)

Finding Importance for Universal Screening of Familial Hypercholesterolemia
por: Yokoyama, Shinji
Publicado: (2022)

Familial hypercholesterolemia supravalvular aortic stenosis and extensive atherosclerosis
por: Prajapati, Rajpal, et al.
Publicado: (2018)

Ancestry-Dependent Enrichment of Deleterious Homozygotes in Runs of Homozygosity
por: Szpiech, Zachary A., et al.
Publicado: (2019)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Stakeholder Views on Active Cascade Screening for Familial Hypercholesterolemia
por: van El, Carla G., et al.
Publicado: (2018)

Universal Screening for Familial Hypercholesterolemia in Children in Kagawa, Japan
por: Matsunaga, Keiji, et al.
Publicado: (2022)

A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes
por: Bastard, Paul, et al.
Publicado: (2022)

Screening and clinical characteristics analysis of familial hypercholesterolemia in a tertiary public hospital
por: Shen, Tianzhou, et al.
Publicado: (2023)

Cascade screening for familial hypercholesterolemia-identification of the C308Y mutation in multiple family members and relatives for the first time in mainland China
por: Jin, Weirong, et al.
Publicado: (2019)

Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia
por: Bell, Damon A, et al.
Publicado: (2012)

Impact of the severe familial hypercholesterolemia status on atherosclerotic risks
por: Tada, Hayato, et al.
Publicado: (2023)

Establishment of Homozygote Mutant Human Embryonic Stem Cells by Parthenogenesis
por: Epsztejn-Litman, Silvina, et al.
Publicado: (2015)

Homozygote Depression in Gamete-Derived Dragon-Fruit (Hylocereus) Lines
por: Li, Daqing, et al.
Publicado: (2018)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
por: Ginsberg, Henry N., et al.
Publicado: (2019)

Genetic variations in familial hypercholesterolemia and cascade screening in East Asians
por: Chan, Melody Lok‐Yi, et al.
Publicado: (2018)

CASCADE screening and registry of familial hypercholesterolemia in Iran: Rationale and design
por: Vaseghi, Golnaz, et al.
Publicado: (2019)

Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients
por: Salgado, María, et al.
Publicado: (2023)

Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia
por: Silva, Pãmela Rodrigues de Souza, et al.
Publicado: (2018)

Predictors of Family Recruitment in a Program of Genetic Cascade Screening for Familial Hypercholesterolemia
por: Izar, Maria Cristina de Oliveira, et al.
Publicado: (2018)

Homozygous familial hypercholesterolemia
por: Parihar, Ravi Kumar, et al.
Publicado: (2012)

Homozygous Familial Hypercholesterolemia
por: Nohara, Atsushi, et al.
Publicado: (2021)

Applications of machine learning in familial hypercholesterolemia
por: Luo, Ren-Fei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_62cujtaa1v5g5icaqgamh8i3g2